Medarex, Inc. · Princeton, NJ United States
| 707 State Rd. | Phone: 609-430-2880 |
| Princeton, NJ | Fax: 609-430-2850 |
| 08540 | |
| United States | 
Map This Company |
Medarex, Inc. Rankings
Company Description
Medarex was building the ultimate monoclonal antibody. Its UltiMAb technology utilized transgenic mice with supressed antibody gene expressions to create fully human monoclonal antibodies (single-source proteins). Medarex had more than 40 antibodies for cancer, rheumatoid arthritis, and other autoimmune, inflammatory, and infectious diseases in clinical trials or pre-trial stages. The company had partnerships with numerous pharma and biotech firms including
Medarex, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Subsidiary |
|---|---|
| Fiscal Year-End | December |
Executives
18 executives listed for Medarex, Inc.'s Princeton, NJ location.
| Chairman Emeritus | Irwin Lerner | |
|---|---|---|
| Chairman, President, and CEO | Howard Pien | |
| SVP and Scientific Director | Nils Lonberg |